Head-to-head · WeighScore
Rewinding RX vs Thriving Again
The verdict
Too close to call — both grade 59.5/100 (C).
Rewinding RX and Thriving Again land on the same WeighScore, so neither clears the other on our six graded dimensions. Rewinding RX sits one line higher on the board (#340 vs #341) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Rewinding RX | Thriving Again |
|---|---|---|
| WeighScore | 59.5/100 | 59.5/100 |
| Grade | C | C |
| Scorecard rank | #340 | #341 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #340 · C
Strengths
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer — uncommon transparency
- MD-only physician network ('never a physician assistant or nurse')
- All-50-state coverage with physician state-licensing matching
- Corporate entity disclosed (Rewinding RX Ltd.)
Where it loses points
- Pricing not shown — fully gated behind sign-up
- Pharmacy partner not named (only generic 503A/503B references)
- Medical director / clinical leadership not disclosed
- Governing law, arbitration venue, and corporate address not disclosed
- Tirzepatide not listed on the homepage (semaglutide only confirmed)
Graded #341 · C
Strengths
- Compounded GLP-1 with at-home labs and ongoing provider messaging
- Advertises nationwide coverage with 500+ licensed providers
- Pre-filled syringe delivery simplifies dosing
- Combines weight loss with hormone and peptide optimization
Where it loses points
- No specific GLP-1 dose or monthly pricing published online
- Weight loss is one vertical alongside men's hormone and TRT care
- Compounded products are not FDA-approved or evaluated
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.